Search clinical trials for: Ramucirumab DP (IMC-1121B)
Total 87 results
-
Eli Lilly and CompanyCompletedHepatocellular CarcinomaUnited States, Canada, Belgium, Germany, Israel, Korea, Republic of, Spain, Australia, Austria, Brazil, France, Italy, Japan, Portugal, Taiwan, Romania, Bulgaria, Czech Republic, Finland, Hong Kong, Hungary, Netherlands, Norway, Phili... and more
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompletedGastric CancerUnited States, Australia, Belgium, Korea, Republic of, Russian Federation, Germany, Poland, Spain, Argentina, Austria, Brazil, Bulgaria, Chile, Estonia, France, Hungary, Israel, Italy, Japan, Lithuania, Mexico, Portugal, Romania, Sing... and more
-
Eli Lilly and CompanyCompletedHepatocellular CarcinomaUnited States
-
Eli Lilly and CompanyCompletedAdvanced Solid TumorsUnited States
-
Eli Lilly and CompanyCompletedCarcinoma of Urinary Tract | Urethral Carcinoma | Carcinoma of Ureter | Carcinoma of Renal PelvisUnited States, Canada
-
Eli Lilly and CompanyParexelCompleted
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyNo longer availableMetastatic Gastric Cancer | Metastatic Adenocarcinoma of the Gastroesophageal JunctionGermany, Netherlands, Austria, Greece, Korea, Republic of
-
Eli Lilly and CompanyCompletedBreast CancerUnited States, Canada, Australia, Belgium, Brazil, Croatia, Czechia, Egypt, Germany, Ireland, Israel, Korea, Republic of, Lebanon, New Zealand, Peru, Poland, Russian Federation, Serbia, Slovakia, South Africa, Spain, Taiwan, United...
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CarcinomaUnited States, United Kingdom
-
Eli Lilly and CompanyCompletedGastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaUnited States, Poland, Romania, Hungary, Russian Federation, Australia, France, Argentina, United Kingdom, New Zealand, Turkey, Slovakia
-
Eli Lilly and CompanyChildren's Oncology GroupCompletedRecurrent Tumor | Pediatric Solid Tumor | Refractory Tumor | CNS MalignanciesUnited States
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompletedRenal Cell Carcinoma | Non-Small Cell Lung Cancer | Gastric Adenocarcinoma | Advanced Cancer | Hepatocellular Cancer | Gastroesophageal Junction AdenocarcinomaUnited States
-
Eli Lilly and CompanyCompletedRectal Cancer | Colon CancerUnited States, Canada
-
Eli Lilly and CompanyCompletedMetastatic Renal Cell CarcinomaUnited States
-
Eli Lilly and CompanyMerck Sharp & Dohme LLCCompletedCarcinoma, Transitional Cell | Gastric Adenocarcinoma | Non-small Cell Lung Cancer | Biliary Tract Cancer | Adenocarcinoma of the Gastroesophageal JunctionGermany, United States, Spain, United Kingdom, France, Japan
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Completed
-
Eli Lilly and CompanyCompletedAdenocarcinoma | Gastric CancerUnited States, Canada, Brazil, Czechia, Egypt, Korea, Republic of, Lebanon, Poland, Russian Federation, Spain, Romania, United Kingdom, Australia, Croatia, Italy, Philippines, Thailand, Argentina, Bosnia and Herzegovina, Chile, ... and more
-
Eli Lilly and CompanyCompletedMalignant Solid TumorUnited States
-
Eli Lilly and CompanyCompletedCarcinoma, Non-Small-Cell LungUnited States, Germany, Poland, Belgium, Canada, United Kingdom
-
Eli Lilly and CompanyCompletedProstate CancerUnited States
-
Eli Lilly and CompanyAstraZenecaCompletedHepatocellular Carcinoma | Gastric Cancer | Non-Small Cell Lung Cancer | Gastroesophageal Junction AdenocarcinomaUnited States, Spain, Korea, Republic of, Taiwan, Germany, Italy, France, Israel
-
Eli Lilly and CompanyCompletedMalignant Solid TumorUnited States
-
Eli Lilly and CompanyCompletedBreast Cancer | Metastatic Breast CancerJapan
-
Eli Lilly and CompanyCompletedNon-Small Cell Lung CancerUnited States, Germany, Israel, Italy, Mexico, France, Poland, Romania, Spain, Taiwan, United Kingdom, Hungary, Austria, Argentina, Korea, Republic of, Greece, Turkey, India, Netherlands, Russian Federation, Canada, Norway, Sweden, Br... and more
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedCholangiocarcinoma | Liver and Intrahepatic Bile Duct Carcinoma | Unresectable Gallbladder Carcinoma | Stage III Gallbladder Cancer AJCC v7 | Stage IIIA Gallbladder Cancer AJCC v7 | Stage IIIB Gallbladder Cancer AJCC v7 | Stage IV Gallbladder Cancer AJCC v7 | Stage IVA Gallbladder Cancer AJCC v7 | Stage... and other conditionsUnited States
-
Eli Lilly and CompanyCompletedSolid TumorsUnited States
-
SCRI Development Innovations, LLCCelgeneCompletedGastroesophageal CancerUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI); Eli Lilly and Company; Merck Sharp & Dohme LLCRecruitingStage IV Lung Cancer AJCC v8 | Recurrent Lung Non-Small Cell CarcinomaUnited States
-
Eli Lilly and CompanyCompletedColorectal CarcinomaJapan
-
Eli Lilly and CompanyNo longer availableGastric Cancer | Gastroesophageal Junction Adenocarcinoma
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompletedNon-small Cell Lung Cancer MetastaticJapan
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerUnited States, United Kingdom
-
Eli Lilly and CompanyCompletedMetastatic Malignant MelanomaUnited States
-
Eli Lilly and CompanyCompletedGastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaItaly, United States, Spain, Ukraine, Germany, Greece, Czechia, Turkey, Belgium, Sweden, Canada
-
Ohio State University Comprehensive Cancer CenterActive, not recruitingMetastatic Lung Non-Small Cell Carcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Recurrent Lung Non-Small Cell CarcinomaUnited States
-
Eli Lilly and CompanyCompletedMetastatic Gastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaGermany, Italy, Spain, United States, Hungary, Russian Federation, Poland, Belgium, Netherlands, France, Czechia, Mexico, Argentina, Canada, Denmark, Finland, Israel, Japan, Puerto Rico, United Kingdom
-
University of Southern CaliforniaNational Cancer Institute (NCI); IpsenWithdrawnGastric Adenocarcinoma | Metastatic Gastroesophageal Junction Adenocarcinoma | Unresectable Gastroesophageal Junction Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma | Locally Advanced Unresectable Gastric Adenocarcinoma | Metastatic Unresectable Gastric AdenocarcinomaUnited States
-
Eli Lilly and CompanyCompletedMetastatic Gastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaKorea, Republic of, Taiwan, Japan
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI); Eli Lilly and CompanyCompletedAdult Glioblastoma MultiformeUnited States
-
Eli Lilly and CompanyCompleted
-
Innovent Biologics (Suzhou) Co. Ltd.TerminatedA Study of Sintilimab Plus Ramucirumab as First-line Treatment for G/EGJ Adenocarcinoma (ORIENT-106)Gastric AdenocarcinomaChina
-
Emory UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLCRecruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Metastatic Non-Small Lung Cell Cancer | Recurrent Non-Small Lung Cell CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Esophageal Carcinoma | Recurrent Gastric Carcinoma | Metastatic Gastroesophageal Junction Adenocarcinoma | Unresectable Gastroesophageal Junction Adenocarcinoma | Metastatic Esophageal Carcinoma | Metastatic Gastric Carcinoma | Stage IV Esophageal Cancer AJCC v7 | Stage IV Gastric Cancer... and other conditionsUnited States